November 19, 2012 at 10:46 AM EST
Changshan Pharma and ConjuChem Form $3 Million Diabetes JV
Hebei Changshan Biochemical Pharma will form a JV with ConjuChem LLC, a privately owned Los Angeles company that is developing a long-acting form of insulin. The JV will work towards gaining SFDA approval for the product in China. ConjuChem is owned by Dr. Patrick Soon-Shiong, the man behind the very successful cancer drug Abraxane®. Abraxane is a form of paclitaxel that allows more of the drug’s active ingredient to reach the tumor. More details.... Stock Symbol: (SHE: 300255) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here